BioNexus Gene Lab Corp. Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent
BioNexus Gene Lab Corp. (BGLC) reported Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent of -$44.63 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent · last filed 2022-05-16
- BioNexus Gene Lab Corp. other comprehensive income (loss), foreign currency translation adjustment, tax, portion attributable to parent for the quarter ending 2022-03-31 was -$44.63K.
- BioNexus Gene Lab Corp. other comprehensive income (loss), foreign currency translation adjustment, tax, portion attributable to parent for the quarter ending 2021-09-30 was -$33.52K, a 123.66% decline year-over-year.
- BioNexus Gene Lab Corp. other comprehensive income (loss), foreign currency translation adjustment, tax, portion attributable to parent for the quarter ending 2021-06-30 was -$18.30K, a 159.63% decline year-over-year.
- BioNexus Gene Lab Corp. other comprehensive income (loss), foreign currency translation adjustment, tax, portion attributable to parent for the quarter ending 2021-03-31 was -$124.08K.
- BioNexus Gene Lab Corp. other comprehensive income (loss), foreign currency translation adjustment, tax, portion attributable to parent for fiscal 2019 was $9.73K, a 147.44% increase from fiscal 2018.
- BioNexus Gene Lab Corp. other comprehensive income (loss), foreign currency translation adjustment, tax, portion attributable to parent for fiscal 2018 was $3.93K.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent 3 month as first filed | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent 6 month as first filed | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent 9 month as first filed | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|---|---|---|
| 2022-03-31 | -$44.63K 10-Q · filed 2022-05-16 | ||||||
| 2021-09-30 | -$33.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$51.82K derived: sum of 2 quarters · filed 2021-11-15 | -$175.90K 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | -$18.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$142.38K 10-Q · filed 2021-08-12 | |||||
| 2021-03-31 | -$124.08K 10-Q · filed 2022-05-16 | ||||||
| 2020-09-30 | $141.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $172.34K derived: sum of 2 quarters · filed 2021-11-15 | -$18.49K 10-Q · filed 2021-11-15 | -$11.37K 10-Q · filed 2020-11-03 | $2.41K derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $30.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$160.14K 10-Q · filed 2021-08-12 | -$24.67K 10-Q · filed 2020-08-11 | -$139.23K derived: sum of 3 quarters · filed 2021-08-12 | -$149.96K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | -$190.83K 10-Q · filed 2021-05-18 | -$26.32K 10-Q · filed 2020-05-08 | -$169.92K derived: sum of 2 quarters · filed 2021-05-18 | -$180.65K derived: sum of 3 quarters · filed 2021-05-18 | -$200.61K derived: sum of 4 quarters · filed 2021-05-18 | ||
| 2019-12-31 | $20.91K derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-03-31 | $10.18K derived: sum of 2 quarters · filed 2020-11-09 | -$9.78K derived: sum of 3 quarters · filed 2020-11-09 | $9.73K 10-K · filed 2020-03-31 | |||
| 2019-09-30 | -$10.72K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-09 | -$30.69K derived: sum of 2 quarters · filed 2020-11-09 | -$11.17K 10-Q/A · filed 2020-11-09 | $34.19K derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | -$19.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$451.00 10-Q · filed 2020-08-11 | $44.91K derived: sum of 3 quarters · filed 2020-08-11 | $16.19K derived: sum of 4 quarters · filed 2020-08-11 | |||
| 2019-03-31 | $19.51K 10-Q · filed 2020-05-08 | $64.88K derived: sum of 2 quarters · filed 2020-05-08 | $36.15K derived: sum of 3 quarters · filed 2020-05-08 | $51.03K derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2018-12-31 | $45.36K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | $16.64K derived: sum of 2 quarters · filed 2020-03-31 | $31.52K derived: sum of 3 quarters · filed 2020-03-31 | $3.93K 10-K · filed 2020-03-31 | |||
| 2018-09-30 | -$28.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$13.84K derived: sum of 2 quarters · filed 2019-11-14 | -$41.43K 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | $14.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$12.70K 10-Q · filed 2019-08-09 | |||||
| 2018-03-31 | -$27.59K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |